Incretin based therapy for Type 2 Diabetes Mellitus
Journal Title: The Indian Practitioner - Year 2014, Vol 67, Issue 9
Abstract
Type 2 Diabetes Mellitus (T2DM) is associated with obesity, insulin resistance, beta-cell dysfunction and hyperglucagonaemia, leading to hyperglycaemia. With the currently available antidiabetic agents, long term glycaemic control remains poor and attaining a glycosylated Hb (HbA1c) of < 7% is often not achievable. Further the antidiabetic agents available induce weight gain (except metformin), hypoglycaemia and have a negligible effect on beta-cell dysfunction. New classes of drugs that affect incretin hormones show promise in the treatment of T2DM. Incretins i.e. Glucagon-like peptide (GLP-1) and glucose-dependent insulinotropic peptides (GIP) are peptide hormones secreted from the gut in response to ingestion of food and enhance the glucose-stimulated insulin secretion from the pancreas. T2DM patients are resistant to the insulin secreting action of GIP but are responsive to GLP-1. Therefore, GLP-1 shows promise in the treatment of T2DM as it enhances glucose-stimulated insulin secretion and there are less chances of hypoglycaemia. In addition, it promotes insulin biosynthesis, suppresses glucagon secretion, improves fasting and post-prandial blood sugar, HbA1c, inhibits gastric emptying, reduces appetite and food intake. Further, GLP-1 has been found to prevent or reverse the destruction of β cells in preclinical studies and is also associated with beneficial effect on cardio-vascular risk factor including blood pressure (BP), weight, endothelial dysfunction and lipid profiles. The clinical use of GLP-1 is limited by its short t½ of 2 minutes, due to its degradation by the enzyme, dipeptidyl peptidase-4 (DPP-4). To combat this problem, drugs have been developed to increase the level of GLP-1 in the body i.e. GLP-1 receptor agonist (incretin mimetics) and DPP-4 inhibitors (incretin enhancers).
Authors and Affiliations
J Kaur, G Kwatra, DK Badyal
Keywords
Related Articles
- EP ID EP583418
- DOI -
- Views 52
- Downloads 0
Comparative study on the dermatoglyphic pattern among diabetic (type-2) and non-diabetic adults in North Indian population
Dermatoglyphics is the study of epidermal ridges and their configurations. The appearance of it in individuals is genetically determined; as the diabetes mellitus also has a genetic background; one can assume that there...
Primary Tubercular Myositis
A 41 yr male presented with left lower back swelling and discomfort in the right thigh since 2 months. There was no history of fever, weight loss, anorexia or any other pulmonary complaints. There was no history of traum...
Case of Friedreich Ataxia: Affecting 3 Members of a Family
Friedreich’s ataxia (FA) is an autosomal recessive inherited disorder, characterised by degeneration of the sensory neurons in the spinal cord, posterior column (tract of Gall and Burdach), pyramidal tracts. We report a...
Weight Loss in Healthy Neonates in First Three Days of Life
Aims: (1) To evaluate the weight loss in healthy breastfed neonates in first three days of their life. (2) To compare the weight loss between different periods of gestation and different birth weight. Purpose: This study...
Health Seeking Behaviour and Practices for Sicknesses in Rural Communities
Health providers need to know disease burden of communities they serve and the communities’ health seeking behaviour and practices. The study was conducted in 28 villages in eastern part of Maharashtra, India. Diary appr...